title: Significant haemoglobinopathies: guidelines for screening and diagnosis.
authors.affiliation: Department of Haematology, Manchester Royal Infirmary, UK.
authors.forename: Kate
authors.initials: K
authors.lastname: Ryan
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Bain
authors.forename: David
authors.initials: D
authors.lastname: Worthington
authors.forename: Jacky
authors.initials: J
authors.lastname: James
authors.forename: Dianne
authors.initials: D
authors.lastname: Plews
authors.forename: Anthony
authors.initials: A
authors.lastname: Mason
authors.forename: David
authors.initials: D
authors.lastname: Roper
authors.forename: David C
authors.initials: DC
authors.lastname: Rees
authors.forename: Barbara
authors.initials: B
authors.lastname: de la Salle
authors.forename: Allison
authors.initials: A
authors.lastname: Streetly
mesh_terms: D000755:Anemia, Sickle Cell / Q000175:diagnosis; D005260:Female; D006453:Hemoglobinopathies / Q000175:diagnosis*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008403:Mass Screening / Q000379:methods* / Q000592:standards; D018579:Patient Selection; D016742:Preconception Care / Q000379:methods; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods; D011785:Quality Assurance, Health Care / Q000379:methods; D013789:Thalassemia / Q000175:diagnosis